9,333 results on '"Carcinoma, Intraductal, Noninfiltrating"'
Search Results
2. Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
3. Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
4. Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
5. A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
6. Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial (VEnT)
7. Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma (NORDIS)
8. DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
9. Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
10. Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery
11. Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
12. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
13. Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
14. Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) (ELISA)
15. High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
16. Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
17. Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
18. Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
19. Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
20. Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NOVEMBER)
21. Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
22. Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer (MI-CISDIR)
23. MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
24. Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion (TOLERANT)
25. Metformin and Nightly Fasting in Women With Early Breast Cancer
26. Intraoperative Radiation Therapy (IORT) in DCIS
27. Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
28. Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
29. Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
30. Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer
31. Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
32. Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
33. Breast MRI as a Preoperative Tool for DCIS
34. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
35. Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
36. A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant (007)
37. Reoperation Rate in Breast-Conserving Surgery Using Confocal Histolog® Scanner for Intraoperative Margin Assessment (SHIELD)
38. Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
39. Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
40. Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS (COMET)
41. Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy (CAREFOR)
42. Abbreviated Breast MRI After Cancer Treatment
43. Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
44. Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
45. Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery (WI223281)
46. Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
47. Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
48. Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions (VAPEX)
49. Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
50. Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.